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Marco Matteo Cicconea, Elene Bilianoub, Alberto Balbarinic,
Michele Gesualdoa, Lorenzo Ghiadonid, Marco Metrae, Pasquale Palmierof,
Roberto Pedrinellic, Massimo Salvettig, Pietro Scicchitanoa, Annapaola Zitoa,
Salvatore Novoh and Anna Vittoria MattioliiAtherosclerosis and its complications are the most
important causes of death all over the world, especially
in Western countries. Diet habits, modern stress life,
smoking, sedentary way of life and an involvement of
genetic pattern of individuals lead to a sure degeneration
of quality of life increasing the risk of atherosclerosis
development. For this reason, the main purpose of actual
medicine is to identify all the markers that could allow
the physicians to evaluate the first moments of the
development of this dangerous pathological process.
The aim is to reduce the speed of its evolution, trying to
delay indefinitely the risk coming from the morphological
alterations of the vessels. ‘Endothelium function’ could
allow physicians to detect the first moment of the natural
history of atherosclerosis process. Its impairment is the
first step in the degeneration of vascular structures.
Many methods [flow-mediated vasodilatation (FMD);
antero-posterior abdominal aorta diameter (APAO); intima-
media thickness of the common carotid artery (CCA-IMT);
arterial stiffness; and so on] try to evaluate its function, but
many limitations come from general population
characteristics. A standardization of the methods should
take into account individuals’ peculiarities. Two elements,opyright © Italian Federation of Cardiology. Una
1558-2027  2013 Italian Federation of Cardiologynot modifiable, should be taken into account for vascular
evaluation: age and sex. The aim of this review is to outline
the linkage among age, sex and instrumental evaluation of
patients considered for a noninvasive assessment of their
cardiovascular risk profile.
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Atherosclerosis and its complications are the leading
causes of death worldwide. Its pathogenesis deals with
inflammation and autoimmune aspects well developed in
the literature.1 It seems to grow from childhood. In fact,
lipid entrapment, oxidation and their shape-changing in
vessel walls lead to a chronic inflammatory state, which
turns transformation of the former ‘fatty streaks’ into a
real fibrous plaque, susceptible to future rupture, throm-
bosis and stenosis.
In 1976, Ross and Glomset2 outlined the inflammatory
nature of the atherosclerotic process and its relationship
with all the components of endothelial organ and its
cells (circulating or adhering to the vessel walls). Inter-
national research3–5 tried to explain the fundamental
mechanism at the basis of the atherosclerosis, outlining
the great influence of damaged vascular endothelium
and circulating factors in inducing the development
of plaque.Moreover, hypertension,5 obesity,6 smoking,7 dyslipide-
mia,5 diabetes5 and even age8 and sex9 have an important
role in continuing such a systemic illness, leading to a
faster growth during individuals’ life period.
Research developed early markers of atherosclerosis.
Instrumental examinations [intima–media thickness of
common carotid artery (CCA-IMT), arterial stiffness,
ankle-brachial index (ABI), antero-posterior abdominal
aorta diameter (APAO), flow-mediated vasodilatation
(FMD), left ventricular hypertrophy (LVH) and so on]
have been employed to evaluate its function. The aim of
this review is to evaluate the effect of age and sex on the
early markers of atherosclerosis, in order to better under-
stand how such parameters can influence the precocious
identification of the disease.
Brachial artery flow-mediated vasodilatation
The endothelium is an autocrine–paracrine organ that
plays an important role in regulating vascular tone byuthorized reproduction of this article is prohibited.
DOI:10.2459/JCM.0b013e328362078d
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stances that act on endothelial cells.
Its impairment, so-called ‘endothelial dysfunction’, is the
earliest event in the atherosclerotic process.10
The FMD technique is a validated instrumental tool able
to detect endothelial function status.10
Implementing rules
An electronic probe is positioned 4–5 cm above the
elbow to obtain right brachial artery longitudinal
scanning. After 1min resting period in supine position,
a blood pressure (BP) cuff is inflated to 250mmHg for
exactly 5min,11 then rapidly deflated. The following
reactive hyperemia induces an increase in brachial artery
diameter due to nitric oxide production. The FMD is the
ratio of diameter change (maximumbaseline) to base-
line:
FMD ¼ ½ðpost-hyperemia diameter
 baseline diameterÞ=baseline diameter
 100:
(see also Fig. 1). Normal values are those greater than
5–10%.11
Clinical impact
Sex seems to really influence artery dilatation induced by
nitric oxide. Celermajer et al.12 first demonstrated that apyright © Italian Federation of Cardiology. Unau
Fig. 1
A sample case of brachial artery flow-mediated vasodilatation evaluation. It
and after-deflation measurements.reduced FMD is related to older age (r¼0.34,
P< 0.0001) and sex. In men, FMD was preserved in
individuals aged 40 years or less but declined thereafter
at 0.21% per year. In women, FMD was stable until the
early 50s, after which it declined at 0.49% per year
(P¼ 0.002 compared with men). Thus, age induced
progressive endothelial dysfunction in normal humans,
and this occurred earlier in men than in women. In
women, a steep decline starts at menopause. Tomiyama
et al.13 also found a negative correlation among FMD and
age/sex (beta¼0.19, P< 0.01, beta¼0.024, P< 0.01,
respectively) and this provided evidence as to how these
could be considered independent variables related to the
impairment of FMD. Jensen-Urstad and Johansson14
highlighted the relationship between sex and age on
vascular function. FMD-induced vasodilatation is smal-
ler in women at 55 years of age than at 35 years of age, and
similar in 35- to 55-year-old men and in men and women
at 55 years of age.14 The Cardiovascular Risk in Young
Finns Study15 exalted FMD reproducibility differences
between sexes and postulated that this could be due to
differences in risk factors and vessel size.
Interestingly, a persistently reduced FMD after short-
term antihypertensive treatment was predictive of cardio-
vascular events in a cohort of postmenopausal women.16
However, Hu et al.17 showed a similar predictive value of
FMD in men and women without significant coronary
artery disease (CAD), as also shown in hypertensive
patients.18 No explanation had been proposed for this,thorized reproduction of this article is prohibited.
is the percentage increase in brachial artery diameter between baseline
CEarly markers of atherosclerosis Ciccone et al. 759but the difference could be due to natural differences
between sexes. Estrogen imbalance between sexes could
partially explain the discrepancy.19
In conclusion, it is well known that age alters the vascular
structure naturally and independently. Such degeneration
impairs endothelial function and, consequentially, FMD,
even considering ‘healthy’ individuals, that is personswith
no cardiovascular risks.20 Age ‘per se’ is a natural predictor
of impaired endothelial function and for this reason should
be well analysed when physicians would like to detect the
early moments of the atherosclerotic process. Ryliskyte
et al.21 tried to extrapolate the normative value of FMD in
patients with low cardiovascular risk profile. They ana-
lysed normal individuals according to their different ages
(115 individuals with mean ages 44.19þ 12.23 years and a
range of 26–83 years), in order to point out the normative
value of FMD at different ages of life. Ciccone et al.,22 by
considering only children, measured the normal value of
FMDofbrachial artery inyoungageas almost equal to 10%
(men: 8.29þ 3.21% and women: 8.29þ 3.48%) indepen-
dent of sex. With increasing age, FMD reduces its value
(to 6%), varying according to sexual characteristics.
Further larger, possibly multicentre, studies are import-
ant to assess the real burden that age and sex could have
on FMD and the role of many biases that affect FMD
evaluation23–26.
Antero-posterior abdominal aorta diameter
Implementing rules
APAO is defined as the maximal external cross-sectional
measurement, calculated as the distance between the
near and the far walls of the abdominal aorta. Measure-
ments were performed at 0.5, 1 and 2 cm above the
umbilicus and were expressed in centimetres27 (Fig. 2).
Clinical impact
The APAO has been always related to abdominal aortic
aneurysms, but it is recently becoming an atherosclerotic
marker,28 influenced by sex and age. Norman et al.29opyright © Italian Federation of Cardiology. Una
Fig. 2
Measurements of antero-posterior abdominal aorta diameter.indicated infrarenal aortic diameter as a real predictor
of all-cause mortality by analysing 12 203 men aged
65–83 years. Patel et al.30 reached the same results in a
female population.
APAO as an atherosclerotic cardiovascular risk factor is a
well-developed issue in the literature.31 Sonesson et al.32
showed no differences in aortic diameter between men
and women with smoking habits, although women were
characterized by an aortic stiffness higher than men, and
this sign seemed to indicate that the aorta of women
might be more vulnerable to smoking with regard to
stiffening and degeneration than the aorta of men.
Men with an increased APAO had a higher incidence
of peripheral vascular diseases than the opposite sex.33,34
Male sex seems to be an important determinant in
developing enlargement of abdominal aorta diameter
and, consequentially, cardiovascular ischemic diseases
(i.e. acute coronary syndromes and proven coronary
stenosis).28,35
An important proceeding about the matter comes from
the manuscript of Ciccone et al.27 They considered young
women suffering with polycystic ovary syndrome (PCOS)
and showed that increased APAO is the earliest arterial
alteration in women with PCOS, preceding CCA-IMT
alterations. The work links age and sex in the evaluation
of APAO: female sex and age influence the development
of increasing abdominal aorta diameter and, in this way,
worsen the natural history of the atherosclerotic process.
Grimshaw and Thompson,36 although considering only
men in their evaluation, found that an increase in aortic
diameter could impair prognosis in patients. Similar
results came from the research by Palombo et al.,37 once
again concerning measuring of abdominal aorta diameter
in old age but in patients with abdominal aorta aneurysm.
Wilmink et al.,38 instead, investigated the natural
relationship between age and APAO. Data from their
analysis of 3066 women and 8270 men added evidence
that APAO effectively increased with age.38 Olderuthorized reproduction of this article is prohibited.
Co
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worsening in aortic diameter than younger ones.38 Long
et al.35 and Allison et al.28 confirmed these data. The
relationship between APAO and age had been well
shown in a ‘visual and anato-pathological’ analysis by
Sawabe et al.39 in 833 consecutive autopsy cases (616 men
and 217 women). The age at death ranged from 20 to 94
years, with an average of 59.2 years. They noticed that
age really contributes to aortic dilatation, more than
atherosclerotic burden. Thus, age influences the analysis
of APAO.
Intima-media thickness of the common
carotid artery
CCA-IMT is the most international validated cardiovas-
cular risk marker.40 Many works41–44 have revealed its
importance in the early detection of atherosclerosis.45
Implementing rules
Patients are placed in a supine position, the neck
extended and turned contralaterally by about 458. The
CCA-IMT is defined as the distance between the lumen-
intima and media-adventitia borders of the vessel, ultra-
sonographically identified by a double hypoechoic line
not projecting into the vessel lumen46 (Fig. 3). Echo-
measurements should be made in three zones: proximal
zone: about 2 cm above the flow-divider; distal zone:
about half centimetre above the flow-divider; and middle
zone. The arithmetical mean CCA-IMT value (mCCA-
IMT) should be calculated.
Clinical impact
Age and sex could impair CCA-IMT. The CAMP study
by Ciccone et al.42 involved four Italian centres (Lecco;
Pisa; Bari; Palermo) in order to establish the normal meanpyright © Italian Federation of Cardiology. Unau
Fig. 3
Carotid intima-media thickness evaluation.Italian values of CCA-IMT, adjusted for age and sex. One
thousand and seventeen healthy individuals without any
cardiovascular risk factors (596 men and 421 women),
aged between 22 and 85 years (mean 58.5þ 13.2 years),
were studied. The data allowed tables of percentiles for
normal CCA-IMT values in Italy to be drawn up accord-
ing to sex and age. CCA-IMT was positively correlated
with age and mean values were higher in men than in
women. Also, Novo et al.47 pointed out the importance of
CCA-IMT and carotid plaque in picturing the cardio-
vascular risk profile of patients older than 45 years,
underlining the role of CCA-IMT in evaluating the
preclinical stages of the atherosclerosis.48
Sex is ‘per se’ a known parameter able to heavily influ-
ence the evaluation of CCA-IMT. Such consideration
comes not only from the previous work of Ciccone et al.42
but also from other work.15 The research by Bo¨hm et al.49
on 267 healthy pupils (aged 6–17 years) pointed out a
clear difference between sexes for CCA-IMT values
since childhood. These findings contrast those of
the MESA study50 wherein no influence of sex on
CCA-IMT was found.
Studies51,52 underlined a negative influence of female sex
on CCA-IMT. The importance of female sex emerges by
considering the effects of hormone changes during
women’s life.53 Ciccone et al.54 demonstrated that obese
women affected early on by Hashimoto’s thyroiditis
develop impairment of vascular structure at carotid level.
The same results are reported in premenopausal or
menopausal women.43,55 On the contrary, men had an
increased cardiovascular risk profile just in relationship to
their own habits and constitution.56
The CAMP study42 showed age influencing CCA-IMT,
due to the natural history and progression of atherosclero-
tic process. Barra et al.57 underlined the early increase of
CCA-IMT in children whose relatives/parents suffered
with premature myocardial infarction. The Cardiovascu-
lar Risk in Young Finns study58 indicates that children
with risk factors have increased atherosclerosis pro-
gression rate in adulthood, although, according to Ygando
et al.,59 cardiorespiratory fitness improves CCA-IMT
values even in adults, that is in patients in whom vessel
structural alterations had become more severe. Finally,
Takato et al.60 suggested that sexual differences exist in
the relationship with CCA-IMT and age increase. Thus,
the CAMP study42 is a really basic study, as it points out
the natural development of CCA-IMT values through
years in an Italian population and it greatly links the age
of patients to their own sex and to CCA-IMT values.
These considerations really improve the diagnostic
power of CCA-IMT and help physicians to better picture
the clinical conditions of the patients.
Nevertheless, despite the influences of age and sex on
CCA-IMT, literature data61 affirm the importance of
CCA-IMT as a surrogate parameter of systemicthorized reproduction of this article is prohibited.
CEarly markers of atherosclerosis Ciccone et al. 761atherosclerotic process in the assessment of cardiovascu-
lar risk profile of individuals since the early periods of
their lives.
Ankle-brachial index
Implementing rules
The ABI is a simple, noninvasive test, measuring the SBP
from both brachial arteries and from both the dorsalis
pedis and posterior tibial arteries after the patient has
been at rest in the supine position for 10min.62 It is
obtained by dividing the highest ankle systolic pressure
by the highest brachial systolic pressure.62
Clinical impact
The ABI is used both to screen for peripheral arterial
disease (PAD) and to establish its diagnosis with a high
degree of accuracy (sensitivity: 79–95%; specificity:
95–100%). A normal ABI is above 1.10, whereas PAD
is generally defined as a resting ABI of 0.90 or less.62
Considered before as a basic tool to quantify the severity
of occlusive disease, the ABI has more recently become a
marker of cardiovascular risk, associated with an
increased risk of myocardial infarction and death and
able to improve Framingham risk score prognostic role.63
Age and sex could impair ABI. A low ABI is common in
the elderly, with a prevalence more than 25% in individ-
uals older than 85 years,64 associated with increased risk
of death, global cardiovascular diseases (CVDs), coronary
heart disease and symptomatic PAD.65 A low ABI in the
elderly has been shown to increase risk (more than six-
fold) for coronary heart disease mortality in both men and
women (mean age: 66 years) with large-vessel PAD, as
Criqui et al.66 demonstrated. Interestingly, Murabito
et al.67 found that a low ABI was both independently
and inversely related to the risk of stroke or transient
ischemic attack in elderly persons with and without CVD
at baseline, but not with risk of CAD or death. Never-
theless, methodological pitfalls could be outlined: dia-
betic patients or very elderly individuals’ pressure cannot
be abolished by inflation of an air-filled BP cuff (non-
compressible pedal arteries); a high ABI is thought to
represent stiff arterial walls, potentially including medial
arterial calcification. Therefore, the value for the ankle
artery sometimes is not an accurate measure of intra-
arterial pressure but rather a falsely high value due to
stiffness in the arterial wall. However, the relative risk of
cardiovascular mortality in the low ABI cohort was
increased approximately three-fold to four-fold in a
cohort of 1537 elderly men and women followed in the
Systolic Hypertension in the Elderly Program.68
Among older individuals, the prevalence of PAD is
similar to, or even slightly higher, in women than in
men. McDermott et al.69 found that at 47 months of
follow-up, women with PAD were more likely to become
unable to walk for 6min continuously, and they had a
higher incidence of mobility loss and faster declines in 6-opyright © Italian Federation of Cardiology. Unamin walk distance than in men with PAD, maybe due to
baseline sexual differences (lower calf muscle area and
reduced knee extension strength in women) in functional
performance. Among Spanish people, the effect of cal-
culating ABI on the reclassification of cardiovascular risk
categorized by the principle functions (Framingham-
Wilson, REGICOR and SCORE) induced changes in
category risk. Reclassification was stronger in women;
according to SCORE, the high-risk category increases by
50%; according to Framingham-Wilson, it increases
by 78.6%; and according to REGICOR, it increases by
151.6%.70 Moreover, patients with ABI less than 0.9 were
older, more frequently men, and had a worse profile for all
the cardiovascular risk factors.70
The importance of sex emerges above all when consider-
ing the effects of hormone changes throughout women’s
life. Several population-based studies have suggested
that the prevalence of a low ABI is more common in
women.71 In patients undergoing elective coronary angio-
graphy, women had a higher prevalence of PAD than in
men and a lower prevalence and severity of CAD,
although the mechanisms are still unclear.71 Intriguingly,
men are more than twice as likely to be selected for lower
extremity revascularizations, even after adjusting for limb
salvage, age, ABI, comorbidity and smoking.72
Genetic polymorphism could influence ABI index.73
The GG genotype of single nucleotide polymorphism
rs11066001 of BRAP (a protein participating in the lym-
photoxin-alpha-associated inflammatory pathways,
associated, if altered, with myocardial infarction) in
women was significantly associated with a lower ABI
value than in men with the same genotype, maybe the
cause is a different sexual action of release of inflamma-
tory molecules associated with this gene.
Left ventricular hypertrophy
LVH is a compensatory process that represents an adap-
tation to increased ventricular wall stress in hypertension.
It is also the first step towards the development of overt
clinical disease such as congestive heart failure, ischemic
heart disease and sudden death. An increasing prevalence
of vascular alterations in patients with increased left
ventricular mass and/or concentric geometry has been
demonstrated.74,75 Conversely, atherosclerosis can
adversely affect left ventricular dimensions, volumes,
wall thickness and mass.76,77 Echocardiography is much
more sensitive than electrocardiography in LVH detec-
tion.78
Implementing rules
To estimate LVH, we measure interventricular septal
and posterior wall thickness and left ventricular internal
dimension. Parasternal long-axis acoustic window could
be used.78 Systolic and diastolic left ventricular internal
dimensions should be measured at the level of the left
ventricular minor axis, approximately at the mitral valveuthorized reproduction of this article is prohibited.
Co
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cardiography.78 Furthermore, left ventricular mass may
be easily derived from parasternal measurements with
the following formula:78
LVmass ¼ 0:8  f1:04½ðLVIDdþ PWTdþ SWTdÞ3
 ðLVIDdÞ3g þ 0:6g
Clinical impact
The possible influence of sex and age should be taken
into account in the interpretation of the results. Chien
et al.79 underlined the importance of LVH as a predictor
of cardiovascular risk burden of young persons, by con-
sidering 523 boys and 555 girls, aged 12–15 years. They
demonstrated a significant positive correlation between
left ventricular mass and age; furthermore, age and BMI
were the most important determinants of echocardio-
graphic left ventricular mass in young adolescents.79 In
parallel with a progressive increase in left ventricular
mass, ageing is also associated with a transition towards
a significant increase in relative wall thickness,80 an
independent predictor of cardiovascular events.81,82
Therefore, age alters normal geometry of the left
ventricle (LV) and the normal pattern of ventricular
contractility. Dyssynchrony, in fact, could be the natural
evolution of the complex interaction between age and
ventricular tissue abnormalities.83 Even considering
30- to 50-year-old patients with low short-term risk for
CVD, a high lifetime predicted risk of CVD is associated
with concentric left ventricular hypertrophy.82 In the
end, LVH can be considered as a marker of metabolic
and hemodynamic changes leading to atherosclerotic
disease. Hypertension, ischemic heart disease, kidney
disease and other conditions related to the atherosclerotic
process could affect left ventricular mass with increasing
age, as suggested by the evidence of a relationship
between LVH and CCA-IMT84 and/or carotid plaques.
Interestingly, sex also seems to exert a relevant influence
on left ventricular structural and functional proper-
ties:85,86 LVH prevalence and left ventricular concentric
geometry are greater in women than in men with pro-
gressive ageing. In the Framingham population,85 the
prevalence of echocardiographically detected LVH
increased dramatically with age, and in particularly in
women. The prevalence of LVH was more common in
young men, whereas in older individuals, a higher preva-
lence of LVH in women was observed (from 4.6% in
<30 years old to 49% in >70 years old).
De Simone et al.87 reported a significant contribution of
adipose mass and waist-to-hip ratio to variability of left
ventricular mass in women but not in men. The LIFE
study88,89 suggested that the presence of LVH may be
associated with a greater increase in cardiovascular risk in
women than in men. Therefore, the differences in LVH
regression, together with the greater prevalence of LVH,
might contribute to the explanation of the steeperpyright © Italian Federation of Cardiology. Unauincrease in the risk of cardiovascular events with ageing
in hypertensive women.90
Arterial stiffness
Arterial wall stiffness, an independent risk factor for
cardiovascular events, is evaluated by several methods.91
Pulse wave analysis92,93 allows the estimation of indices
of global arterial stiffness and central (aortic) pressures.
In case of stiffer arteries, pulse wave velocity (PWV) is
increased and an earlier return of the reflected wave
increases systolic pressure. The ‘augmentation index’,
that is the difference between the second and first
systolic peaks, expressed as a percentage of the
pulse pressure, may be taken as a rough measure of
global arterial stiffness. The prognostic significance of
augmentation index and central pressures is high,91,93,94
although normal values for these indices are needed.
Carotid to femoral PWV is the most widely accepted
index of arterial stiffness and is currently considered the
‘gold standard’ for aortic stiffness.91 It has a predictive
value for all-cause and cardiovascular mortality, fatal and
nonfatal coronary events, and fatal strokes in different
subsets of patients,91 largely independent from other
cardiovascular risk factors, including age and sex.95
Implementing rules
Assessment of PWV is performed by directly measuring
the transit time of the pulse wave and the distance
between the two sites of measurement; PWV is
measured as delta distance/delta time. It is easy and
reproducible,91 although it should be better standar-
dized. Effectively, PWV assessment has undergone sev-
eral limitations that could impair results of literature
studies. For example, the evaluation of peripheral
PWV does not resemble the central one because of
different responses of systemic vessel wall stiffness to
pressure, which could impair evaluations. Heart rate and
its regularity could alter the evaluation of this parameter,
becoming confounding factors to be considered in the
analysis. And, finally, even age and sex could limit the
evaluation of PWV.
Clinical impact
Ageing exerts a strong influence on arterial functional
properties. In the Asklepios study population,96 femoral
(i.e. muscular artery) stiffness was higher in men than in
women. In the same population, carotid (i.e. an elastic
artery) stiffness showed a faster increase with age in
women than in men. On the contrary, carotid-femoral
PWV increased to a similar extent in men and women. A
significant difference in mechanical behavior has been
observed between elastic arteries at different sites: Paini
et al.97 reported that the aorta more rapidly stiffens with
ageing than the carotid artery. Ageing exerts a strong
influence on arterial mechanical properties. After
50 years of age, there is a linear increase in SBP and athorized reproduction of this article is prohibited.
CEarly markers of atherosclerosis Ciccone et al. 763decline in DBP, thus pulse pressure progressively
widens. This is due to the increase in arterial stiffness
with ageing. Progressive degeneration of elastin fibres
and deposition of collagen play a major role in age-
related arterial stiffening; also, the increase in calcium
content in the arterial wall, particularly after the fifth
decade, might also contribute to the loss of distensibility.
The age-related changes in mechanical properties of
large arteries are heterogeneous, with a relevant decrease
of distensibility only at the level of the more central
‘elastic’ arteries and much less evident changes in the
‘muscular’ peripheral arteries. In the wide sample of
general population included in the Anglo-Cardiff
Collaborative Trial,98 aortic and brachial PWV, peri-
pheral and central pulse pressure and augmentation
index all significantly increased with age. The study
showed that augmentation index could be a more sensi-
tive index of stiffening in younger individuals and the
PWV in the older ones. Interestingly, no difference
between men and women in either aortic or brachial
PWV was observed. Augmentation index was signifi-
cantly correlated with age, and values were higher in
women than in men at each decade of life, in line with
previous findings indicating increased wave reflection in
women. Plantinga et al.99 observed a sex-specific effect of
the metabolic syndrome on central augmentation indexopyright © Italian Federation of Cardiology. Una
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Effect of assessment of pulse wave velocity on cardiovascular risk stratificain a group of hypertensive and normotensive individuals,
which was higher in untreated hypertensive womenwith
the metabolic syndrome, a finding in agreement with
previous results obtained in treated hypertensive
women.100 On the contrary, in the same group of
patients, the metabolic syndrome impaired aortic PWV
to a similar extent in both sexes.99 The impact of age on
aortic stiffness is also underlined by the results of a
review of the literature published in 2009101 in which
age accounted for 23.5% (from 2.0 to 53.0% in the various
studies) of the variance of aortic PWV; among the
other factors analysed, BP explained between 1.8 and
41.0% (mean: 13.8%) of variance in aortic PWV, whereas
the other factors had only a marginal effect. Of note,
normal and reference values for aortic PWV have been
recently published.102 The results have been derived
from the Reference Values for Arterial Stiffness Collab-
oration database, which includes data on 16 867 individ-
uals and patients from 13 different centres across eight
European countries.102 Interestingly, aortic PWV was
strongly affected by age and BP, whereas sexual differ-
ences in aortic PWV were negligible,103 even after
adjusting for possible confounders. The assessment of
aortic PWV may significantly ameliorate cardiovascular
risk stratification in addition to other parameters103
(Fig. 4).uthorized reproduction of this article is prohibited.
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Atherosclerosis and its consequences represent an ever
present social and health problem all over the world. As
previously outlined, physicians are now able to detect the
first moments of its development, thanks to new instru-
mental and noninvasive techniques based, above all, on
the adoption of ultrasounds. CCA-IMT, ABI, APAO,
brachial artery FMD, LVH and aortic stiffness evaluated
by means of PWV are all able to identify early patho-
logical moments of vascular wall changes due to athero-
sclerosis development. Nevertheless, age and sex could
really influence the detection of these parameters. Thus,
perception of these confounding factors should be con-
sidered by physicians when evaluating early markers
of atherosclerosis.
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